Global Decongestant Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

Global Decongestant Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

Table of Contents
1 Report Overview
1.1 Research Scope
1.2 Market Segment by Type
1.2.1 Global Decongestant Market Size Growth Rate by Type (2017 VS 2021 VS 2028)
1.2.2 Tablets
1.2.3 Capsules
1.2.4 Nasal Sprays
1.3 Market Segment by Application
1.3.1 Global Decongestant Market Share by Application (2017 VS 2021 VS 2028)
1.3.2 Hospitals
1.3.3 Research & Academic Laboratories
1.3.4 Clinic
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
2 Market Perspective
2.1 Global Decongestant Market Size (2017-2028)
2.1.1 Global Decongestant Revenue (2017-2028)
2.1.2 Global Decongestant Sales (2017-2028)
2.2 Global Decongestant Market Size across Key Geographies Worldwide: 2017 VS 2021 VS 2028
2.2.1 Global Decongestant Sales by Regions (2017-2022)
2.2.2 Global Decongestant Revenue by Regions (2017-2022)
2.3 Global Decongestant Market Size Forecast by Region
2.3.1 Global Decongestant Sales Forecast by Region (2023-2028)
2.3.2 Global Decongestant Revenue Forecast by Region (2023-2028)
2.4 Global Top Decongestant Regions (Countries) Ranking by Market Size
2.5 Decongestant Market Dynamics
2.5.1 Decongestant Market Trends
2.5.2 Decongestant Market Drivers
2.5.3 Decongestant Market Challenges
2.5.4 Decongestant Market Restraints
3 Competitive Landscape by Manufacturers
3.1 Global Top Decongestant Manufacturers by Sales (2017-2022)
3.1.1 Global Decongestant Sales by Manufacturers (2017-2022)
3.1.2 Global Decongestant Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global 5 and 10 Largest Manufacturers by Decongestant Sales in 2021
3.2 Global Top Manufacturers Decongestant by Revenue
3.2.1 Global Decongestant Revenue by Manufacturers (2017-2022)
3.2.2 Top Decongestant Manufacturers Covered: Ranking by Revenue
3.2.3 Global Decongestant Revenue Share by Manufacturers (2017-2022)
3.2.4 Global Decongestant Market Concentration Ratio (CR5 and HHI)
3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Decongestant as of 2021)
3.4 Global Decongestant Average Selling Price (ASP) by Manufacturers
3.5 Key Manufacturers Decongestant Plants/Factories Distribution and Area Served
3.6 Date of Key Manufacturers Enter into Decongestant Market
3.7 Key Manufacturers Decongestant Product Offered
3.8 Mergers & Acquisitions, Expansion Plans
4 Global Decongestant Market Size by Type
4.1 Global Decongestant Historic Market Review by Type (2017-2022)
4.1.1 Global Decongestant Sales Market Share by Type (2017-2022)
4.1.2 Global Decongestant Revenue Market Share by Type (2017-2022)
4.1.3 Decongestant Price by Type (2017-2022)
4.2 Global Decongestant Market Estimates and Forecasts by Type (2023-2028)
4.2.1 Global Decongestant Sales Forecast by Type (2023-2028)
4.2.2 Global Decongestant Revenue Forecast by Type (2023-2028)
4.2.3 Decongestant Price Forecast by Type (2023-2028)
5 Global Decongestant Market Size by Application
5.1 Global Decongestant Historic Market Review by Application (2017-2022)
5.1.1 Global Decongestant Sales Market Share by Application (2017-2022)
5.1.2 Global Decongestant Revenue Market Share by Application (2017-2022)
5.1.3 Decongestant Price by Application (2017-2022)
5.2 Global Decongestant Market Estimates and Forecasts by Application (2023-2028)
5.2.1 Global Decongestant Sales Forecast by Application (2023-2028)
5.2.2 Global Decongestant Revenue Forecast by Application (2023-2028)
5.2.3 Decongestant Price Forecast by Application (2023-2028)
6 North America
6.1 North America Decongestant Sales Breakdown by Company
6.1.1 North America Decongestant Sales by Company (2017-2022)
6.1.2 North America Decongestant Revenue by Company (2017-2022)
6.2 North America Decongestant Market Size by Type
6.2.1 North America Decongestant Sales by Type (2017-2028)
6.2.2 North America Decongestant Revenue by Type (2017-2028)
6.3 North America Decongestant Market Size by Application
6.3.1 North America Decongestant Sales by Application (2017-2028)
6.3.2 North America Decongestant Revenue by Application (2017-2028)
6.4 North America Decongestant Market Size by Country
6.4.1 North America Decongestant Sales by Country (2017-2028)
6.4.2 North America Decongestant Revenue by Country (2017-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Decongestant Sales Breakdown by Company
7.1.1 Europe Decongestant Sales by Company (2017-2022)
7.1.2 Europe Decongestant Revenue by Company (2017-2022)
7.2 Europe Decongestant Market Size by Type
7.2.1 Europe Decongestant Sales by Type (2017-2028)
7.2.2 Europe Decongestant Revenue by Type (2017-2028)
7.3 Europe Decongestant Market Size by Application
7.3.1 Europe Decongestant Sales by Application (2017-2028)
7.3.2 Europe Decongestant Revenue by Application (2017-2028)
7.4 Europe Decongestant Market Size by Country
7.4.1 Europe Decongestant Sales by Country (2017-2028)
7.4.2 Europe Decongestant Revenue by Country (2017-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
8 Asia Pacific
8.1 Asia Pacific Decongestant Sales Breakdown by Company
8.1.1 Asia Pacific Decongestant Sales by Company (2017-2022)
8.1.2 Asia Pacific Decongestant Revenue by Company (2017-2022)
8.2 Asia Pacific Decongestant Market Size by Type
8.2.1 Asia Pacific Decongestant Sales by Type (2017-2028)
8.2.2 Asia Pacific Decongestant Revenue by Type (2017-2028)
8.3 Asia Pacific Decongestant Market Size by Application
8.3.1 Asia Pacific Decongestant Sales by Application (2017-2028)
8.3.2 Asia Pacific Decongestant Revenue by Application (2017-2028)
8.4 Asia Pacific Decongestant Market Size by Region
8.4.1 Asia Pacific Decongestant Sales by Region
8.4.2 Asia Pacific Decongestant Revenue by Region
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 India
8.4.7 Australia
8.4.8 Taiwan
8.4.9 Indonesia
8.4.10 Thailand
8.4.11 Malaysia
8.4.12 Philippines
8.4.13 Vietnam
9 Latin America
9.1 Latin America Decongestant Sales Breakdown by Company
9.1.1 Latin America Decongestant Sales by Company (2017-2022)
9.1.2 Latin America Decongestant Revenue by Company (2017-2022)
9.2 Latin America Decongestant Market Size by Type
9.2.1 Latin America Decongestant Sales by Type (2017-2028)
9.2.2 Latin America Decongestant Revenue by Type (2017-2028)
9.3 Latin America Decongestant Market Size by Application
9.3.1 Latin America Decongestant Sales by Application (2017-2028)
9.3.2 Latin America Decongestant Revenue by Application (2017-2028)
9.4 Latin America Decongestant Market Size by Country
9.4.1 Latin America Decongestant Sales by Country (2017-2028)
9.4.2 Latin America Decongestant Revenue by Country (2017-2028)
9.4.3 Mexico
9.4.4 Brazil
9.4.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Decongestant Sales Breakdown by Company
10.1.1 Middle East and Africa Decongestant Sales by Company (2017-2022)
10.1.2 Middle East and Africa Decongestant Revenue by Company (2017-2022)
10.2 Middle East and Africa Decongestant Market Size by Type
10.2.1 Middle East and Africa Decongestant Sales by Type (2017-2028)
10.2.2 Middle East and Africa Decongestant Revenue by Type (2017-2028)
10.3 Middle East and Africa Decongestant Market Size by Application
10.3.1 Middle East and Africa Decongestant Sales by Application (2017-2028)
10.3.2 Middle East and Africa Decongestant Revenue by Application (2017-2028)
10.4 Middle East and Africa Decongestant Market Size by Country
10.4.1 Middle East and Africa Decongestant Sales by Country (2017-2028)
10.4.2 Middle East and Africa Decongestant Revenue by Country (2017-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 U.A.E
11 Company Profiles
11.1 Mylan N.V.
11.1.1 Mylan N.V. Corporation Information
11.1.2 Mylan N.V. Overview
11.1.3 Mylan N.V. Decongestant Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.1.4 Mylan N.V. Decongestant Products and Services
11.1.5 Mylan N.V. Decongestant SWOT Analysis
11.1.6 Mylan N.V. Recent Developments
11.2 Teva Pharmaceutical Industries Ltd.
11.2.1 Teva Pharmaceutical Industries Ltd. Corporation Information
11.2.2 Teva Pharmaceutical Industries Ltd. Overview
11.2.3 Teva Pharmaceutical Industries Ltd. Decongestant Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.2.4 Teva Pharmaceutical Industries Ltd. Decongestant Products and Services
11.2.5 Teva Pharmaceutical Industries Ltd. Decongestant SWOT Analysis
11.2.6 Teva Pharmaceutical Industries Ltd. Recent Developments
11.3 Ranbaxy Laboratories Ltd.
11.3.1 Ranbaxy Laboratories Ltd. Corporation Information
11.3.2 Ranbaxy Laboratories Ltd. Overview
11.3.3 Ranbaxy Laboratories Ltd. Decongestant Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.3.4 Ranbaxy Laboratories Ltd. Decongestant Products and Services
11.3.5 Ranbaxy Laboratories Ltd. Decongestant SWOT Analysis
11.3.6 Ranbaxy Laboratories Ltd. Recent Developments
11.4 Beximco Pharmaceuticals Ltd.
11.4.1 Beximco Pharmaceuticals Ltd. Corporation Information
11.4.2 Beximco Pharmaceuticals Ltd. Overview
11.4.3 Beximco Pharmaceuticals Ltd. Decongestant Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.4.4 Beximco Pharmaceuticals Ltd. Decongestant Products and Services
11.4.5 Beximco Pharmaceuticals Ltd. Decongestant SWOT Analysis
11.4.6 Beximco Pharmaceuticals Ltd. Recent Developments
11.5 Novartis AG
11.5.1 Novartis AG Corporation Information
11.5.2 Novartis AG Overview
11.5.3 Novartis AG Decongestant Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.5.4 Novartis AG Decongestant Products and Services
11.5.5 Novartis AG Decongestant SWOT Analysis
11.5.6 Novartis AG Recent Developments
11.6 Cipla Ltd.
11.6.1 Cipla Ltd. Corporation Information
11.6.2 Cipla Ltd. Overview
11.6.3 Cipla Ltd. Decongestant Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.6.4 Cipla Ltd. Decongestant Products and Services
11.6.5 Cipla Ltd. Decongestant SWOT Analysis
11.6.6 Cipla Ltd. Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Decongestant Value Chain Analysis
12.2 Decongestant Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Decongestant Production Mode & Process
12.4 Decongestant Sales and Marketing
12.4.1 Decongestant Sales Channels
12.4.2 Decongestant Distributors
12.5 Decongestant Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
List of Tables
Table 1. Global Decongestant Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Tablets
Table 3. Major Manufacturers of Capsules
Table 4. Major Manufacturers of Nasal Sprays
Table 5. Global Decongestant Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global Decongestant Market Size (US$ Million) by Region: 2017 VS 2021 VS 2028
Table 7. Global Decongestant Sales by Region (2017-2022) & (K Units)
Table 8. Global Decongestant Sales Market Share by Region (2017-2022)
Table 9. Global Decongestant Revenue by Region (2017-2022) & (US$ Million)
Table 10. Global Decongestant Revenue Market Share by Region (2017-2022)
Table 11. Global Decongestant Sales Forecast by Region (2023-2028) & (K Units)
Table 12. Global Decongestant Sales Market Share Forecast by Region (2023-2028)
Table 13. Global Decongestant Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 14. Global Decongestant Revenue Market Share Forecast by Region (2023-2028)
Table 15. Top Decongestant Regions (Countries) Ranking by Market Size (US$ Million) in 2021
Table 16. Decongestant Market Trends
Table 17. Decongestant Market Drivers
Table 18. Decongestant Market Challenges
Table 19. Decongestant Market Restraints
Table 20. Global Decongestant Sales by Manufacturers (2017-2022) & (K Units)
Table 21. Global Decongestant Sales Share by Manufacturers (2017-2022)
Table 22. Global Decongestant Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 23. Ranking of Global Top Decongestant Manufacturers by Revenue (US$ Million) in 2021
Table 24. Decongestant Revenue Share by Manufacturers (2017-2022)
Table 25. Global Decongestant Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 26. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Decongestant as of 2021)
Table 27. Key Manufacturers Decongestant Average Selling Price (ASP) & (2017-2022) & (USD/Unit)
Table 28. Key Manufacturers Decongestant Plants/Factories Distribution
Table 29. Key Manufacturers Decongestant Area Served
Table 30. Date of Key Manufacturers Enter into Decongestant Market
Table 31. Key Manufacturers Decongestant Product Type
Table 32. Mergers & Acquisitions, Expansion Plans
Table 33. Global Decongestant Sales (K Units) by Type (2017-2022)
Table 34. Global Decongestant Sales Share by Type (2017-2022)
Table 35. Global Decongestant Revenue (US$ Million) Market Share by Type (2017-2022)
Table 36. Global Decongestant Price (K Units) by Type (2017-2022)
Table 37. Global Decongestant Sales (K Units) by Type (2023-2028)
Table 38. Global Decongestant Sales Share by Type (2023-2028)
Table 39. Global Decongestant Revenue (US$ Million) Market Share by Type (2023-2028)
Table 40. Global Decongestant Revenue Share by Type (2023-2028)
Table 41. Global Decongestant Price (K Units) by Type (2023-2028)
Table 42. Global Decongestant Sales (K Units) by Application (2017-2022)
Table 43. Global Decongestant Sales Share by Application (2017-2022)
Table 44. Global Decongestant Revenue (US$ Million) Market Share by Application (2017-2022)
Table 45. Global Decongestant Price (K Units) by Application (2017-2022)
Table 46. Global Decongestant Sales (K Units) by Application (2023-2028)
Table 47. Global Decongestant Sales Share by Application (2023-2028)
Table 48. Global Decongestant Revenue (US$ Million) Market Share by Application (2023-2028)
Table 49. Global Decongestant Revenue Share by Application (2023-2028)
Table 50. Global Decongestant Price (K Units) by Application (2023-2028)
Table 51. North America Decongestant Sales by Company (2017-2022) & (K Units)
Table 52. North America Decongestant Sales Market Share by Company (2017-2022)
Table 53. North America Decongestant Revenue by Company (2017-2022) & (US$ Million)
Table 54. North America Decongestant Revenue Market Share by Company (2017-2022)
Table 55. North America Decongestant Sales by Type (2017-2022) & (K Units)
Table 56. North America Decongestant Sales by Type (2023-2028) & (K Units)
Table 57. North America Decongestant Revenue by Type (2017-2022) & (US$ Million)
Table 58. North America Decongestant Revenue by Type (2023-2028) & (US$ Million)
Table 59. North America Decongestant Sales by Application (2017-2022) & (K Units)
Table 60. North America Decongestant Sales by Application (2023-2028) & (K Units)
Table 61. North America Decongestant Revenue by Application (2017-2022) & (US$ Million)
Table 62. North America Decongestant Revenue by Application (2023-2028) & (US$ Million)
Table 63. North America Decongestant Sales by Country (2017-2022) & (K Units)
Table 64. North America Decongestant Sales by Country (2023-2028) & (K Units)
Table 65. North America Decongestant Revenue by Country (2017-2022) & (US$ Million)
Table 66. North America Decongestant Revenue by Country (2023-2028) & (US$ Million)
Table 67. Europe Decongestant Sales by Company (2017-2022) & (K Units)
Table 68. Europe Decongestant Sales Market Share by Company (2017-2022)
Table 69. Europe Decongestant Revenue by Company (2017-2022) & (US$ Million)
Table 70. Europe Decongestant Revenue Market Share by Company (2017-2022)
Table 71. Europe Decongestant Sales by Type (2017-2022) & (K Units)
Table 72. Europe Decongestant Sales by Type (2023-2028) & (K Units)
Table 73. Europe Decongestant Revenue by Type (2017-2022) & (US$ Million)
Table 74. Europe Decongestant Revenue by Type (2023-2028) & (US$ Million)
Table 75. Europe Decongestant Sales by Application (2017-2022) & (K Units)
Table 76. Europe Decongestant Sales by Application (2023-2028) & (K Units)
Table 77. Europe Decongestant Revenue by Application (2017-2022) & (US$ Million)
Table 78. Europe Decongestant Revenue by Application (2023-2028) & (US$ Million)
Table 79. Europe Decongestant Sales by Country (2017-2022) & (K Units)
Table 80. Europe Decongestant Sales by Country (2023-2028) & (K Units)
Table 81. Europe Decongestant Revenue by Country (2017-2022) & (US$ Million)
Table 82. Europe Decongestant Revenue by Country (2023-2028) & (US$ Million)
Table 83. Asia Pacific Decongestant Sales by Company (2017-2022) & (K Units)
Table 84. Asia Pacific Decongestant Sales Market Share by Company (2017-2022)
Table 85. Asia Pacific Decongestant Revenue by Company (2017-2022) & (US$ Million)
Table 86. Asia Pacific Decongestant Revenue Market Share by Company (2017-2022)
Table 87. Asia Pacific Decongestant Sales by Type (2017-2022) & (K Units)
Table 88. Asia Pacific Decongestant Sales by Type (2023-2028) & (K Units)
Table 89. Asia Pacific Decongestant Revenue by Type (2017-2022) & (US$ Million)
Table 90. Asia Pacific Decongestant Revenue by Type (2023-2028) & (US$ Million)
Table 91. Asia Pacific Decongestant Sales by Application (2017-2022) & (K Units)
Table 92. Asia Pacific Decongestant Sales by Application (2023-2028) & (K Units)
Table 93. Asia Pacific Decongestant Revenue by Application (2017-2022) & (US$ Million)
Table 94. Asia Pacific Decongestant Revenue by Application (2023-2028) & (US$ Million)
Table 95. Asia Pacific Decongestant Sales by Region (2017-2022) & (K Units)
Table 96. Asia Pacific Decongestant Sales by Region (2023-2028) & (K Units)
Table 97. Asia Pacific Decongestant Revenue by Region (2017-2022) & (US$ Million)
Table 98. Asia Pacific Decongestant Revenue by Region (2023-2028) & (US$ Million)
Table 99. Latin America Decongestant Sales by Company (2017-2022) & (K Units)
Table 100. Latin America Decongestant Sales Market Share by Company (2017-2022)
Table 101. Latin America Decongestant Revenue by Company (2017-2022) & (US$ Million)
Table 102. Latin America Decongestant Revenue Market Share by Company (2017-2022)
Table 103. Latin America Decongestant Sales by Type (2017-2022) & (K Units)
Table 104. Latin America Decongestant Sales by Type (2023-2028) & (K Units)
Table 105. Latin America Decongestant Revenue by Type (2017-2022) & (US$ Million)
Table 106. Latin America Decongestant Revenue by Type (2023-2028) & (US$ Million)
Table 107. Latin America Decongestant Sales by Application (2017-2022) & (K Units)
Table 108. Latin America Decongestant Sales by Application (2023-2028) & (K Units)
Table 109. Latin America Decongestant Revenue by Application (2017-2022) & (US$ Million)
Table 110. Latin America Decongestant Revenue by Application (2023-2028) & (US$ Million)
Table 111. Latin America Decongestant Sales by Country (2017-2022) & (K Units)
Table 112. Latin America Decongestant Sales by Country (2023-2028) & (K Units)
Table 113. Latin America Decongestant Revenue by Country (2017-2022) & (US$ Million)
Table 114. Latin America Decongestant Revenue by Country (2023-2028) & (US$ Million)
Table 115. Middle East and Africa Decongestant Sales by Company (2017-2022) & (K Units)
Table 116. Middle East and Africa Decongestant Sales Market Share by Company (2017-2022)
Table 117. Middle East and Africa Decongestant Revenue by Company (2017-2022) & (US$ Million)
Table 118. Middle East and Africa Decongestant Revenue Market Share by Company (2017-2022)
Table 119. Middle East and Africa Decongestant Sales by Type (2017-2022) & (K Units)
Table 120. Middle East and Africa Decongestant Sales by Type (2023-2028) & (K Units)
Table 121. Middle East and Africa Decongestant Revenue by Type (2017-2022) & (US$ Million)
Table 122. Middle East and Africa Decongestant Revenue by Type (2023-2028) & (US$ Million)
Table 123. Middle East and Africa Decongestant Sales by Application (2017-2022) & (K Units)
Table 124. Middle East and Africa Decongestant Sales by Application (2023-2028) & (K Units)
Table 125. Middle East and Africa Decongestant Revenue by Application (2017-2022) & (US$ Million)
Table 126. Middle East and Africa Decongestant Revenue by Application (2023-2028) & (US$ Million)
Table 127. Middle East and Africa Decongestant Sales by Country (2017-2022) & (K Units)
Table 128. Middle East and Africa Decongestant Sales by Country (2023-2028) & (K Units)
Table 129. Middle East and Africa Decongestant Revenue by Country (2017-2022) & (US$ Million)
Table 130. Middle East and Africa Decongestant Revenue by Country (2023-2028) & (US$ Million)
Table 131. Mylan N.V. Corporation Information
Table 132. Mylan N.V. Description and Overview
Table 133. Mylan N.V. Decongestant Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 134. Mylan N.V. Decongestant Product and Services
Table 135. Mylan N.V. Decongestant SWOT Analysis
Table 136. Mylan N.V. Recent Developments
Table 137. Teva Pharmaceutical Industries Ltd. Corporation Information
Table 138. Teva Pharmaceutical Industries Ltd. Description and Overview
Table 139. Teva Pharmaceutical Industries Ltd. Decongestant Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 140. Teva Pharmaceutical Industries Ltd. Decongestant Product and Services
Table 141. Teva Pharmaceutical Industries Ltd. Decongestant SWOT Analysis
Table 142. Teva Pharmaceutical Industries Ltd. Recent Developments
Table 143. Ranbaxy Laboratories Ltd. Corporation Information
Table 144. Ranbaxy Laboratories Ltd. Description and Overview
Table 145. Ranbaxy Laboratories Ltd. Decongestant Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 146. Ranbaxy Laboratories Ltd. Decongestant Product and Services
Table 147. Ranbaxy Laboratories Ltd. Decongestant SWOT Analysis
Table 148. Ranbaxy Laboratories Ltd. Recent Developments
Table 149. Beximco Pharmaceuticals Ltd. Corporation Information
Table 150. Beximco Pharmaceuticals Ltd. Description and Overview
Table 151. Beximco Pharmaceuticals Ltd. Decongestant Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 152. Beximco Pharmaceuticals Ltd. Decongestant Product and Services
Table 153. Beximco Pharmaceuticals Ltd. Decongestant SWOT Analysis
Table 154. Beximco Pharmaceuticals Ltd. Recent Developments
Table 155. Novartis AG Corporation Information
Table 156. Novartis AG Description and Overview
Table 157. Novartis AG Decongestant Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 158. Novartis AG Decongestant Product and Services
Table 159. Novartis AG Decongestant SWOT Analysis
Table 160. Novartis AG Recent Developments
Table 161. Cipla Ltd. Corporation Information
Table 162. Cipla Ltd. Description and Overview
Table 163. Cipla Ltd. Decongestant Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 164. Cipla Ltd. Decongestant Product and Services
Table 165. Cipla Ltd. Decongestant SWOT Analysis
Table 166. Cipla Ltd. Recent Developments
Table 167. Key Raw Materials Lists
Table 168. Raw Materials Key Suppliers Lists
Table 169. Decongestant Distributors List
Table 170. Decongestant Customers List
Table 171. Research Programs/Design for This Report
Table 172. Key Data Information from Secondary Sources
Table 173. Key Data Information from Primary Sources
List of Figures
Figure 1. Decongestant Product Picture
Figure 2. Global Decongestant Sales Market Share by Type in 2021 & 2028
Figure 3. Tablets Product Picture
Figure 4. Capsules Product Picture
Figure 5. Nasal Sprays Product Picture
Figure 6. Global Decongestant Sales Market Share by Application in 2021 & 2028
Figure 7. Hospitals Use Case
Figure 8. Research & Academic Laboratories Use Case
Figure 9. Clinic Use Case
Figure 10. Other Use Case
Figure 11. Decongestant Report Years Considered
Figure 12. Global Decongestant Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global Decongestant Market Size 2017-2028 (US$ Million)
Figure 14. Global Decongestant Sales (2017-2022) & (K Units)
Figure 15. Global Decongestant Market Size Market Share by Region: 2021 VS 2028
Figure 16. Global Decongestant Sales Market Share by Region (2017-2022)
Figure 17. Global Decongestant Sales Market Share by Region in 2021
Figure 18. Global Decongestant Revenue Market Share by Region in 2017 VS 2021
Figure 19. Global Decongestant Sales Share by Manufacturers in 2021
Figure 20. The 5 and 10 Largest Manufacturers in the World: Market Share by Decongestant Sales in 2021
Figure 21. Decongestant Revenue Share by Manufacturers in 2021
Figure 22. Decongestant Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 23. Global Decongestant Revenue Share by Type (2017-2022)
Figure 24. Global Decongestant Revenue Growth Rate by Type in 2017 & 2021
Figure 25. Global Decongestant Revenue Share by Application (2017-2022)
Figure 26. Global Decongestant Revenue Growth Rate by Application in 2017 & 2021
Figure 27. North America Decongestant Sales Market Share by Type (2017-2028)
Figure 28. North America Decongestant Revenue Market Share by Type (2017-2028)
Figure 29. North America Decongestant Sales Market Share by Application (2017-2028)
Figure 30. North America Decongestant Revenue Market Share by Application (2017-2028)
Figure 31. North America Decongestant Sales Share by Country (2017-2028)
Figure 32. North America Decongestant Revenue Share by Country (2017-2028)
Figure 33. U.S. Decongestant Revenue (2017-2028) & (US$ Million)
Figure 34. Canada Decongestant Revenue (2017-2028) & (US$ Million)
Figure 35. Europe Decongestant Sales Market Share by Type (2017-2028)
Figure 36. Europe Decongestant Revenue Market Share by Type (2017-2028)
Figure 37. Europe Decongestant Sales Market Share by Application (2017-2028)
Figure 38. Europe Decongestant Revenue Market Share by Application (2017-2028)
Figure 39. Europe Decongestant Sales Share by Country (2017-2028)
Figure 40. Europe Decongestant Revenue Share by Country (2017-2028)
Figure 41. Germany Decongestant Revenue (2017-2028) & (US$ Million)
Figure 42. France Decongestant Revenue (2017-2028) & (US$ Million)
Figure 43. U.K. Decongestant Revenue (2017-2028) & (US$ Million)
Figure 44. Italy Decongestant Revenue (2017-2028) & (US$ Million)
Figure 45. Russia Decongestant Revenue (2017-2028) & (US$ Million)
Figure 46. Asia Pacific Decongestant Sales Market Share by Type (2017-2028)
Figure 47. Asia Pacific Decongestant Revenue Market Share by Type (2017-2028)
Figure 48. Asia Pacific Decongestant Sales Market Share by Application (2017-2028)
Figure 49. Asia Pacific Decongestant Revenue Market Share by Application (2017-2028)
Figure 50. Asia Pacific Decongestant Sales Share by Region (2017-2028)
Figure 51. Asia Pacific Decongestant Revenue Share by Region (2017-2028)
Figure 52. China Decongestant Revenue (2017-2028) & (US$ Million)
Figure 53. Japan Decongestant Revenue (2017-2028) & (US$ Million)
Figure 54. South Korea Decongestant Revenue (2017-2028) & (US$ Million)
Figure 55. India Decongestant Revenue (2017-2028) & (US$ Million)
Figure 56. Australia Decongestant Revenue (2017-2028) & (US$ Million)
Figure 57. Taiwan Decongestant Revenue (2017-2028) & (US$ Million)
Figure 58. Indonesia Decongestant Revenue (2017-2028) & (US$ Million)
Figure 59. Thailand Decongestant Revenue (2017-2028) & (US$ Million)
Figure 60. Malaysia Decongestant Revenue (2017-2028) & (US$ Million)
Figure 61. Philippines Decongestant Revenue (2017-2028) & (US$ Million)
Figure 62. Vietnam Decongestant Revenue (2017-2028) & (US$ Million)
Figure 63. Latin America Decongestant Sales Market Share by Type (2017-2028)
Figure 64. Latin America Decongestant Revenue Market Share by Type (2017-2028)
Figure 65. Latin America Decongestant Sales Market Share by Application (2017-2028)
Figure 66. Latin America Decongestant Revenue Market Share by Application (2017-2028)
Figure 67. Latin America Decongestant Sales Share by Country (2017-2028)
Figure 68. Latin America Decongestant Revenue Share by Country (2017-2028)
Figure 69. Mexico Decongestant Revenue (2017-2028) & (US$ Million)
Figure 70. Brazil Decongestant Revenue (2017-2028) & (US$ Million)
Figure 71. Argentina Decongestant Revenue (2017-2028) & (US$ Million)
Figure 72. Middle East and Africa Decongestant Sales Market Share by Type (2017-2028)
Figure 73. Middle East and Africa Decongestant Revenue Market Share by Type (2017-2028)
Figure 74. Middle East and Africa Decongestant Sales Market Share by Application (2017-2028)
Figure 75. Middle East and Africa Decongestant Revenue Market Share by Application (2017-2028)
Figure 76. Middle East and Africa Decongestant Sales Share by Country (2017-2028)
Figure 77. Middle East and Africa Decongestant Revenue Share by Country (2017-2028)
Figure 78. Turkey Decongestant Revenue (2017-2028) & (US$ Million)
Figure 79. Saudi Arabia Decongestant Revenue (2017-2028) & (US$ Million)
Figure 80. U.A.E Decongestant Revenue (2017-2028) & (US$ Million)
Figure 81. Decongestant Value Chain
Figure 82. Decongestant Production Process
Figure 83. Channels of Distribution
Figure 84. Distributors Profiles
Figure 85. Bottom-up and Top-down Approaches for This Report
Figure 86. Data Triangulation
Figure 87. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs